Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough in chemical biology to a validated clinical reality. In…
Read More

Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough in chemical biology to a validated clinical reality. In…
Read More
Proteolysis Targeting Chimera (PROTAC) technology has officially transitioned from a visionary academic concept to a cornerstone of modern clinical pharmacology.…
Read More
The landscape of modern pharmacology shifted fundamentally in May 2026 with the U.S. Food and Drug Administration’s approval of vepdegestrant,…
Read More
The landscape of modern pharmacology shifted fundamentally in May 2026, when the U.S. Food and Drug Administration (FDA) granted approval…
Read More
In the dense, seasonally inundated forests of the western Amazon, a small, unassuming amphibian has emerged as a significant indicator…
Read More
Proteolysis Targeting Chimera (PROTAC) technology has transitioned from a theoretical breakthrough to a cornerstone of modern oncology, fundamentally altering how…
Read More
The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…
Read More
In a significant advancement for the field of renewable energy and carbon capture, a research team at Osaka Metropolitan University…
Read More
In a significant stride toward sustainable energy independence, a research team at Osaka Metropolitan University (OMU) has unveiled a pioneering…
Read More
New data released by Europe’s leading infectious disease agency reveals a concerning decade-high surge in bacterial sexually transmitted infections (STIs),…
Read More